Welcome to our dedicated page for Aflac news (Ticker: AFL), a resource for investors and traders seeking the latest updates and insights on Aflac stock.
Aflac Incorporated (NYSE: AFL) is a Fortune 500 insurer in the direct life and supplemental health insurance space, with major operations in the United States and Japan. The AFL news feed on Stock Titan brings together company-issued updates and market-moving announcements that reflect how Aflac manages its insurance business, capital, partnerships and community initiatives.
Recent Aflac news has covered a range of topics, including quarterly and annual earnings releases, dividend declarations and conference call schedules where management discusses financial results. These items provide insight into segment performance for Aflac U.S. and Aflac Japan, trends in net earned premiums and adjusted earnings, and the company’s approach to capital deployment through dividends and share repurchases.
News stories also highlight Aflac’s strategic partnerships and product-related initiatives. Examples include collaborations to integrate Aflac’s supplemental health products with benefits technology platforms and administrative partners, particularly in the public sector market and employer benefits space. Such announcements illustrate how Aflac connects its supplemental health offerings with employer-sponsored benefits and consumer-directed health care administration.
Aflac’s communications frequently emphasize its role in workplace benefits trends through the Aflac WorkForces Report, which examines employee stress, burnout, financial fragility and the perceived value of supplemental insurance. Other articles focus on the company’s philanthropic efforts, such as support for the Aflac Childhood Cancer Foundation, the My Special Aflac Duck® program and the “Beyond Words” children’s book, all aimed at assisting children and families facing cancer and blood disorders.
Investors and observers following AFL news can use this page to monitor earnings announcements, dividend decisions, risk disclosures, benefits-related research and community initiatives that shape Aflac’s profile as a supplemental health and life insurer. Bookmark this feed to review new press releases and regulatory-related communications as they are issued by the company.
Aflac Incorporated (NYSE: AFL) reported third-quarter results for 2022, with total revenues reaching $4.8 billion, down from $5.2 billion year-over-year. Net earnings rose to $1.6 billion or $2.53 per diluted share, boosted by a $695 million release of deferred taxes. Adjusted earnings fell 29.7% to $725 million, impacted by a 40 million variable investment income loss. Japan segment sales increased 10.2% due to a new product launch, while U.S. sales rose 11.8%. A dividend of $0.40 per share was declared, marking the 40th consecutive year of increases.
Aflac Incorporated announced the retirement of Eric Kirsch, Executive Vice President and Global Chief Investment Officer, effective March 31, 2023. He will be succeeded by Bradley Dyslin, who will take on his new role as of January 1, 2023. Kirsch, who joined Aflac 11 years ago, was instrumental in building a successful global investment team managing over $120 billion in assets. Dyslin, a key hire of Kirsch, has over 30 years of experience and has significantly improved portfolio quality. Both executives emphasized a commitment to strong performance and seamless leadership transition.
Aflac has launched new Dental, Vision and Hearing insurance plans tailored for individuals and families not covered by traditional worksite insurance. This initiative addresses the growing number of Americans in the gig economy and retirees, with 50% of adults 55 and older reportedly out of the labor force due to retirement. The new plans offer three coverage tiers, featuring benefits such as preventive service benefits with no out-of-pocket costs, and decreasing costs for services over time. Aflac aims to fill the insurance coverage gap for those outside traditional employment.
Summary not available.
Aflac Incorporated (NYSE: AFL) will release its third quarter 2022 financial results after the market closes on October 31, 2022. Earnings materials, including an earnings release and financial update video from CFO Max Brodén, will be available on its Investor Relations website. A conference call is scheduled for 8:00 a.m. (ET) on November 1, 2022, where management will discuss results and outlook, with a Q&A session following. Aflac, a leader in supplemental health insurance, serves over 50 million people globally.
Summary not available.
Aflac recently delivered 50 My Special Aflac Ducks to pediatric cancer and sickle cell patients at Children's Hospital New Orleans. This initiative, part of Aflac's commitment to these illnesses, aligns with Childhood Cancer Awareness Month and National Sickle Cell Awareness Month. Since its launch in 2018, over 17,000 ducks have been distributed free of charge. The ducks are designed to comfort children undergoing medical treatments, featuring interactive elements and an innovative design based on extensive research. Aflac has invested over $161 million in support of these communities.
AM Best has assigned a Long-Term Issue Credit Rating of 'a' (Excellent) to the new JPY 73 billion yen-denominated senior unsecured notes from org value="NYSE:AFL"Aflac. The offering includes various maturities and interest rates. Proceeds will help fund Aflac's upcoming debt obligations, increasing its adjusted financial leverage to approximately 25.7% temporarily. Aflac maintains a solid liquidity position with over USD 5.1 billion in cash and equivalents. The outlook for the ratings is stable.
Aflac has partnered with Be The Match to promote diversity in the national blood stem cell donor registry, addressing healthcare inequities for patients with blood cancers. The initiative, supported by NBA player Marcus Smart, aims to register more Aflac employees as donors. Aflac has contributed over $160 million to cancer care since 1995. Following a series of activations in September, including educational programs and a social media campaign, the partnership highlights the disparity in donor matches based on ethnicity, emphasizing the need for diverse representation in donor registries.
Aflac celebrated Childhood Cancer Awareness Month and National Sickle Cell Awareness Month by delivering its award-winning social robot, My Special Aflac Duck, to young patients at Nicklaus Children's Hospital in Miami. This initiative, part of Aflac's $161 million commitment to childhood cancer and blood disorders, aims to provide comfort to children facing these challenges. Since its launch in 2018, Aflac has donated over 17,000 ducks to hospitals nationwide. The duck features an interactive app and customizable soundscapes, enhancing the experience for children undergoing treatment.